Sign Up to like & get
recommendations!
1
Published in 2021 at "Internal Medicine Journal"
DOI: 10.1111/imj.14992
Abstract: Immune checkpoint inhibitors are increasingly being utilised as an effective therapy for a variety of cancers. However, they have the potential to cause serious autoimmune toxicities in multiple organ systems termed ‘immunotherapy‐related adverse events’. Endocrine…
read more here.
Keywords:
immune checkpoint;
checkpoint inhibitors;
effects immune;
endocrine adverse ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.2229
Abstract: Abstract Disclosure: W. Shao: None. K. Yang: None. D. Lu: None. Y. Gao: None. J. Zhang: None. Y. Huang: None. Y. Zhang: None. Background: Tyrosine kinase inhibitor (TKI) and immune checkpoint inhibitor (ICI) individually induce…
read more here.
Keywords:
cohort;
none;
immune checkpoint;
combination ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_47_25
Abstract: Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy by enhancing T-cell-mediated tumour eradication. However, their use is associated with immune-related adverse events, with endocrinopathies being the most common. Thyroid dysfunction, hypophysitis, primary adrenal insufficiency (PAI),…
read more here.
Keywords:
events immune;
adverse events;
immune checkpoint;
endocrine adverse ... See more keywords